Pharmaceutical companies are set to pay nearly $70 million to California over “collusive” deals that kept generic drugs off the market and raised prices 1. august 2019Medicin, Lægemidler, Virkninger & Bi-virkninger, Samfund, Miljø, Historie & Fortid(link-samling), Sundheds-emner(link-samling)Ingen kommentarerJon Ch. Henningsen